Reapplix, a Danish developer of a treatment for diabetic foot ulcers, has raised $20m in funding from investors including North-East Healthcare Investment, Lauxera Capital Partners and MK Ventures.
Novo Holdings et al. in $20m round for Reapplix
Most Popular
